Ryan D Maynard insider trades

Open-market stock purchases and sales by Ryan D Maynard, Director at Iovance Biotherapeutics, Inc, from SEC Form 4 filings since Jan 20, 2010.

Recent trades

DateStockTradeValue
Jun 16, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Feb 23, 2026FHTX Foghorn Therapeutics IncBought (not open market)$2.3M

Companies traded

  • IOVA Iovance Biotherapeutics, Inc: 1 buy, 1 sale, last Jun 16, 2026
  • FHTX Foghorn Therapeutics Inc: other filings, last Feb 23, 2026
  • CARA Cara Therapeutics, Inc: 1 sale, last Feb 1, 2024
  • RIGL Rigel Pharmaceuticals Inc: 9 sales, last Nov 3, 2017
  • LBIO Lion Biotechnologies, Inc: other filings, last Jun 1, 2017

Get free alerts when Ryan D Maynard files a new trade →